Bausch + Lomb Corporation (NYSE:BLCO)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
BLCO Weekly Chart

Old Forum Content for BLCO

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • BarryC: Hello Everyone and whatzzz up!! :-) This is where Im at. #Long: $ATI, $AZEK, $BILL, $BLCO, $CFLT, $EXPI, $MARA, $NVDA, $TSLA & $UPST
  • BarryC: I dumped $BLCO.... Its NOT broken, just have too much others working and not being rewarded. Will still be watching...
  • BarryC: Hello everyone! I put on a few new positions yesterday (called them out here) AND have them on tight leashes.... I went home long# $AZEK, $BILL, $BLCO, $EXPI, $MARA, $NVDA $TSLA & $UPST
  • BarryC: $BLCO worth watching!!!
  • BarryC: Some of the things Im watching: $AZEK, $BILL, $BLCO, $CFLT, $DKNG, $DT, $FND, $HUBS, $SHOP & $TREX
  • BarryC: I bot $BLCO
  • sgiseller: @BarryC $BLCO any idea if this split from $BHC ?
  • scottrades: @BarryC $BLCO Nice chart
  • BarryC: @sgiseller $BLCO $BHC Sorry, I dont...
  • BarryC: @scottrades $BLCO will be nicer IF it works :-)
  • Geewhiz: @sgiseller $BLCO $BHC May 10 2022
    LAVAL, QC and VAUGHAN, ON, May 10, 2022 /PRNewswire/ -- Bausch %2B Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today anno ...
  • BarryC: $BLCO needs some volume to go....
  • BarryC: Two stocks I like the charts: $BLCO & AZEK
  • Henry: @BarryC $BLCO $AZEC nice charts Barry
  • joelsg1: $BLCO Crushed today on drug patent ruling against parent $BHC, putting spinoff in severe jeopardy. Beneficiaries include the other contact lens makers, $JNJ, $ALC and $COO, still my largest pos. even after major trimming, due for run into E 8/31 ( after which expecting it to fall as FX headwinds disappoint). Always sell otm covered calls, but have to wait until closer to E for market demand.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO Check out one you once mentioned after seeing it widely used at SpaceX in a video: $URI. —And feel free to comment. Currently—np.
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Not sure that was me, but a construction play that our dear departed but still living @bRobert setup the short on 1 month ago and well before that. Still under the 200d and gapped above the 20w today. So if this is a change in character, might pb to 20w or even down to 50d and then reassess. Np.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO $URI Thank you for the feedback and, in return, the incriminating evidence: “Agree, fantastic. Feel I have better insight into his management and production style, and thought processes, and think I want to do dd on $URI. Thanks” 2/10/2022 ;)
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Yeah, but I didn't buy it.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO $URI I know, but you’re like EF Hutton: when you post, people listen.
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Uh oh, they're defunct, and as I recall a bunch of crooks with a TV commercial.
  • BocaRick: $BLCO $BHC IPO today open up 6%, but IPO 18 price was below 22-24 estimated IPO price. np
Visit the Trading Forum to join in the discussion.
Stock Price $17.24
Change -0.75%
Volume 594,958

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Request Video of BLCO
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!